BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25175638)

  • 1. Continuous infusion of substance P into rat striatum alleviates nociceptive behavior via phosphorylation of extracellular signal-regulated kinase 1/2.
    Nakamura Y; Izumi H; Fukushige R; Shimizu T; Watanabe K; Morioka N; Hama A; Takamatsu H; Nakata Y
    J Neurochem; 2014 Dec; 131(6):755-66. PubMed ID: 25175638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volume transmission of substance P in striatum induced by intraplantar formalin injection attenuates nociceptive responses via activation of the neurokinin 1 receptor.
    Nakamura Y; Izumi H; Shimizu T; Hisaoka-Nakashima K; Morioka N; Nakata Y
    J Pharmacol Sci; 2013; 121(4):257-71. PubMed ID: 23514787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of substance P into rat striatum relieves mechanical hypersensitivity caused by a partial sciatic nerve ligation via activation of striatal muscarinic receptors.
    Nakamura Y; Fukushige R; Watanabe K; Kishida Y; Hisaoka-Nakashima K; Nakata Y; Morioka N
    Behav Brain Res; 2020 Aug; 391():112714. PubMed ID: 32461131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ERK phosphorylation by substance P N-terminal fragment decreases capsaicin-induced nociceptive response.
    Komatsu T; Mizoguchi H; Sasaki M; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Neuropharmacology; 2011 Sep; 61(4):608-13. PubMed ID: 21601581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of transient receptor potential ankyrin 1 evokes nociception through substance P release from primary sensory neurons.
    Nakamura Y; Une Y; Miyano K; Abe H; Hisaoka K; Morioka N; Nakata Y
    J Neurochem; 2012 Mar; 120(6):1036-47. PubMed ID: 22182301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion of substance P inhibits acute, but not subacute, inflammatory pain induced by complete Freund's adjuvant.
    Nakamura Y; Fukushige R; Watanabe K; Kishida Y; Hisaoka-Nakashima K; Nakata Y; Morioka N
    Biochem Biophys Res Commun; 2020 Dec; 533(4):971-975. PubMed ID: 33008602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supraspinal injection of Substance P attenuates allodynia and hyperalgesia in a rat model of inflammatory pain.
    Parenti C; Aricò G; Ronsisvalle G; Scoto GM
    Peptides; 2012 Apr; 34(2):412-8. PubMed ID: 22306475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral substance P and neurokinin-1 receptors have a role in inflammatory and neuropathic orofacial pain models.
    Teodoro FC; Tronco Júnior MF; Zampronio AR; Martini AC; Rae GA; Chichorro JG
    Neuropeptides; 2013 Jun; 47(3):199-206. PubMed ID: 23177733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin (1-7) Attenuates the Nociceptive Behavior Induced by Substance P and NMDA via Spinal MAS1.
    Yamagata R; Nemoto W; Fujita M; Nakagawasai O; Tan-No K
    Biol Pharm Bull; 2021; 44(5):742-746. PubMed ID: 33952831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rb1 Attenuates Acute Inflammatory Nociception by Inhibition of Neuronal ERK Phosphorylation by Regulation of the Nrf2 and NF-κB Pathways.
    Jang M; Lee MJ; Choi JH; Kim EJ; Nah SY; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
    J Pain; 2016 Mar; 17(3):282-97. PubMed ID: 26548970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the ERK1/2 signaling cascade by excitotoxic spinal cord injury.
    Yu CG; Yezierski RP
    Brain Res Mol Brain Res; 2005 Aug; 138(2):244-55. PubMed ID: 15922485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of spinal protein kinase C blocks substance P-mediated hyperalgesia.
    Wajima Z; Hua XY; Yaksh TL
    Brain Res; 2000 Sep; 877(2):314-21. PubMed ID: 10986346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of tonic nociceptive behavior using a method of substance P-receptor desensitization in the dorsal horn.
    Holland LN; Goldstein BD
    Pain; 1994 Mar; 56(3):339-346. PubMed ID: 7517516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum.
    Shi X; McGinty JF
    Neuroscience; 2006; 138(4):1289-98. PubMed ID: 16459022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2Y1 purinoceptor inhibition reduces extracellular signal-regulated protein kinase 1/2 phosphorylation in spinal cord and dorsal root ganglia: implications for cancer-induced bone pain.
    Chen J; Wang L; Zhang Y; Yang J
    Acta Biochim Biophys Sin (Shanghai); 2012 Apr; 44(4):367-72. PubMed ID: 22349022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of prostaglandin E(2) and nitric oxide from spinal microglia is dependent on activation of p38 mitogen-activated protein kinase.
    Matsui T; Svensson CI; Hirata Y; Mizobata K; Hua XY; Yaksh TL
    Anesth Analg; 2010 Aug; 111(2):554-60. PubMed ID: 20610553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the neurokinin-1 receptor by substance P triggers the release of substance P from cultured adult rat dorsal root ganglion neurons.
    Tang HB; Li YS; Arihiro K; Nakata Y
    Mol Pain; 2007 Dec; 3():42. PubMed ID: 18157919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mitogen-activated protein kinases on chemokine synthesis induced by substance P in mouse pancreatic acinar cells.
    Ramnath RD; Sun J; Adhikari S; Bhatia M
    J Cell Mol Med; 2007; 11(6):1326-41. PubMed ID: 18205703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of substance P (neurokinin-1) receptor activation on rat neostriatal projection neurons.
    Galarraga E; Hernández-López S; Tapia D; Reyes A; Bargas J
    Synapse; 1999 Jul; 33(1):26-35. PubMed ID: 10380848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous descending facilitation and inhibition differ in control of formalin intramuscularly induced persistent muscle nociception.
    Lei J; You HJ
    Exp Neurol; 2013 Oct; 248():100-11. PubMed ID: 23756144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.